XENE XENON PHARMACEUTICALS INC Management Changes 8-K Filing 2025 - Management Change On February 27, 2025, Xenon Pharmaceuticals Inc. announced its financial results for the year ended December 31, 2024, and reported that CFO Sherry Aulin will resign effective June 30, 2025, but will continue to provide advisory services until August 31, 2025.Get access to all SEC 8-K filings of the XENON PHARMACEUTICALS INC